Last Updated: June 24, 2026

Suppliers and packagers for AVAGARD


✉ Email this page to a colleague

« Back to Dashboard


AVAGARD

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Solventum AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074 NDA Solventum US LLC 17518-051-01 8 BOTTLE in 1 CASE (17518-051-01) / 500 mL in 1 BOTTLE 2001-06-14
Solventum AVAGARD alcohol; chlorhexidine gluconate SOLUTION;TOPICAL 021074 NDA Solventum US LLC 17518-051-04 4 BOTTLE in 1 CASE (17518-051-04) / 1200 mL in 1 BOTTLE 2001-06-14
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for AVAGARD (Active Ingredient, Manufacturing, and Contract Supply Chain)

Last updated: May 26, 2026

No complete, accurate supplier map can be produced from the information provided.

Which companies supply AVAGARD, and who manufactures the active ingredient?

No verifiable manufacturer or API supplier list can be compiled for AVAGARD based on the available data.

Is AVAGARD a branded product or a repackaged generic?

No source-backed identification of the product form, strength, dosage form, and sponsor (FDA NDA/ANDA holder) is available, so supplier identification cannot be tied to a specific regulatory listing.

What is the Orange Book status of AVAGARD, and which firms are listed?

No Orange Book extract or listing identifiers are available to confirm:

  • NDA/ANDA application number
  • listed drug (RLD) status
  • applicant/sponsor
  • patent holders
  • exclusivity periods

Which API suppliers and CMOs support AVAGARD manufacturing?

No confirmed supply chain participants (API manufacturers, CMO fill-finish sites, packaging suppliers) are available for AVAGARD.

What manufacturing sites produce AVAGARD tablets/capsules/solutions (by dosage form)?

No dosage form, strength, or manufacturing site details are available to match production locations to specific suppliers.

What patents or regulatory filings link AVAGARD to specific manufacturing contractors?

No patent-to-process or regulatory filing-to-site crosswalk is available.

When does AVAGARD lose exclusivity and open generic supply opportunities?

No FDA exclusivity or patent expiration schedule is available, so generic entry timing and supplier churn cannot be determined.

What generic or biosimilar risks exist for AVAGARD supply continuity?

AVAGARD supplier continuity and competitive entry risk require an FDA/Orange Book or litigation record, which is not available here.

How does AVAGARD compare with alternative brands, and do suppliers overlap?

No verified active ingredient, strength, dosage form, or RLD linkage is available to compare supply networks.

Which distributors and wholesalers handle AVAGARD distribution?

No distribution network data is available to identify authorized distributors or wholesale partners.

Key Takeaways

  • A supplier list for AVAGARD cannot be produced without verified product identifiers (FDA application/RLD link), dosage form/strength, and regulator-published sponsor or manufacturing site information.
  • No Orange Book or patent-lifecycle records are available to connect AVAGARD to specific suppliers, CMOs, or API sources.

FAQs

1) Who is the NDA/ANDA holder for AVAGARD?
Not available.

2) What company manufactures the API used in AVAGARD?
Not available.

3) Are there contract manufacturing organizations (CMOs) behind AVAGARD?
Not available.

4) Is AVAGARD listed in the FDA Orange Book, and which firms are applicants?
Not available.

5) What contract supply risks affect AVAGARD availability?
Not available.

References (APA)

No cited sources available.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.